Legacy Financial Independent Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Legacy Financial Independent Advisors's LLY Position: Q2 2026 in Review
Legacy Financial Independent Advisors reduced its Eli Lilly (LLY) stake by 16% in Q2 2026, selling an estimated $611K and leaving 3,251 shares worth $3.9M. The position accounts for 1.83% of the portfolio, ranked #19.
Legacy Financial Independent Advisors first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,596 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Legacy Financial Independent Advisors held 3,251 shares of Eli Lilly worth $3.9M as of Q2 2026.
- Legacy Financial Independent Advisors sold 598 Eli Lilly shares in Q2 2026, an estimated $611K.
- Eli Lilly made up 1.83% of Legacy Financial Independent Advisors's portfolio in Q2 2026, its #19 holding.
- Legacy Financial Independent Advisors first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
- 4,596 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Legacy Financial Independent Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.